Deutsche Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.8M Sell
888,029
-999,324
-53% -$54.9M 0.02% 616
2025
Q1
$133M Buy
1,887,353
+217,835
+13% +$15.4M 0.05% 339
2024
Q4
$110M Buy
1,669,518
+123,351
+8% +$8.11M 0.04% 402
2024
Q3
$109M Sell
1,546,167
-260,865
-14% -$18.3M 0.04% 376
2024
Q2
$149M Sell
1,807,032
-532,204
-23% -$43.8M 0.07% 259
2024
Q1
$204M Sell
2,339,236
-1,062,961
-31% -$92.8M 0.09% 194
2023
Q4
$328M Buy
3,402,197
+2,003,478
+143% +$193M 0.17% 128
2023
Q3
$124M Sell
1,398,719
-596,287
-30% -$52.8M 0.08% 249
2023
Q2
$173M Sell
1,995,006
-101,769
-5% -$8.82M 0.09% 214
2023
Q1
$204M Sell
2,096,775
-291,991
-12% -$28.4M 0.11% 184
2022
Q4
$247M Buy
2,388,766
+175,192
+8% +$18.1M 0.14% 151
2022
Q3
$188M Buy
2,213,574
+986,996
+80% +$83.7M 0.11% 185
2022
Q2
$102M Buy
1,226,578
+335,397
+38% +$27.8M 0.06% 306
2022
Q1
$68.7M Sell
891,181
-49,914
-5% -$3.85M 0.03% 477
2021
Q4
$83.1M Buy
941,095
+48,216
+5% +$4.26M 0.04% 446
2021
Q3
$69M Sell
892,879
-284,012
-24% -$22M 0.03% 487
2021
Q2
$98.2M Buy
1,176,891
+38,800
+3% +$3.24M 0.05% 380
2021
Q1
$85.9M Buy
1,138,091
+79,716
+8% +$6.02M 0.05% 394
2020
Q4
$92.8M Sell
1,058,375
-315,173
-23% -$27.6M 0.06% 331
2020
Q3
$104M Sell
1,373,548
-118,508
-8% -$9.02M 0.07% 256
2020
Q2
$184M Buy
1,492,056
+8,743
+0.6% +$1.08M 0.14% 140
2020
Q1
$125M Buy
1,483,313
+182,136
+14% +$15.4M 0.11% 183
2019
Q4
$110M Buy
1,301,177
+83,891
+7% +$7.09M 0.07% 277
2019
Q3
$82M Sell
1,217,286
-365,106
-23% -$24.6M 0.06% 343
2019
Q2
$136M Buy
1,582,392
+189,620
+14% +$16.2M 0.08% 266
2019
Q1
$124M Buy
1,392,772
+494,511
+55% +$43.9M 0.07% 291
2018
Q4
$76.5M Sell
898,261
-330,575
-27% -$28.1M 0.05% 371
2018
Q3
$119M Buy
1,228,836
+102,746
+9% +$9.96M 0.06% 342
2018
Q2
$106M Sell
1,126,090
-121,859
-10% -$11.5M 0.05% 373
2018
Q1
$101M Buy
1,247,949
+217,647
+21% +$17.6M 0.05% 388
2017
Q4
$91.9M Sell
1,030,302
-361,778
-26% -$32.3M 0.06% 356
2017
Q3
$130M Buy
1,392,080
+23,140
+2% +$2.15M 0.09% 256
2017
Q2
$124M Buy
1,368,940
+39,727
+3% +$3.61M 0.09% 257
2017
Q1
$117M Sell
1,329,213
-125,349
-9% -$11M 0.09% 264
2016
Q4
$120M Sell
1,454,562
-96,350
-6% -$7.98M 0.1% 250
2016
Q3
$143M Buy
1,550,912
+171,988
+12% +$15.9M 0.1% 226
2016
Q2
$107M Buy
1,378,924
+43,660
+3% +$3.4M 0.08% 301
2016
Q1
$110M Buy
1,335,264
+218,539
+20% +$18M 0.08% 283
2015
Q4
$117M Sell
1,116,725
-99,977
-8% -$10.5M 0.08% 265
2015
Q3
$128M Buy
1,216,702
+49,754
+4% +$5.24M 0.1% 235
2015
Q2
$160M Buy
1,166,948
+41,373
+4% +$5.66M 0.1% 241
2015
Q1
$140M Sell
1,125,575
-26,634
-2% -$3.32M 0.09% 272
2014
Q4
$104M Sell
1,152,209
-195,818
-15% -$17.7M 0.06% 355
2014
Q3
$97.3M Buy
1,348,027
+315,195
+31% +$22.7M 0.06% 345
2014
Q2
$64.2M Buy
1,032,832
+126,504
+14% +$7.87M 0.04% 449
2014
Q1
$61.8M Sell
906,328
-343,099
-27% -$23.4M 0.04% 451
2013
Q4
$87.9M Sell
1,249,427
-422,883
-25% -$29.7M 0.06% 346
2013
Q3
$121M Sell
1,672,310
-400,794
-19% -$28.9M 0.09% 263
2013
Q2
$116M Buy
+2,073,104
New +$116M 0.09% 246